The UK has become the first country in the world to approve a coronavirus vaccine for widespread use after regulators gave the green light to the Pfizer-BioNTech jab. The Medicines and Healthcare ...
The pharma leader is betting that streamlined services may be a shot in the arm for Americans seeking care with its ...
Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...
Company veteran Chris Boshoff, who has led Pfizer’s cancer research and marketing for more than a year, will become chief ...
and how it works? explains Professor Moshi Geso of MRIT ... the vaccine is going through three experimental stages, as is the Pfizer vaccine, but due to the pressure of the spread of Covid-19 ...
The US Food and Drug Administration released safety and efficacy data on Pfizer's novel coronavirus vaccine on Tuesday - and it's looking good. In a 53-page briefing document posted on its website ...
The Pfizer/BioNTech coronavirus vaccine is one ... over 65 years old and data from its phase three trial suggests it works equally well in people of all ages and ethnicities.
One particular drug of Pfizer's, currently named PF-06649751, will be tested in the environment in phase 3 trials in 2019 if initial testing finds the model efficient.
The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr.